Age-related intraneuronal accumulation of αII-spectrin breakdown product SBDP120 in the human cerebrum is enhanced in Alzheimer's disease

Algeciras-Schimnich, 2002, Apoptosis-independent functions of killer caspases, Curr. Opin. Cell Biol., 14, 721, 10.1016/S0955-0674(02)00384-8 Atherton, 2014, Calpain cleavage and inactivation of the sodium calcium exchanger-3 occur downstream of Aβ in Alzheimer's disease, Aging Cell, 13, 49, 10.1111/acel.12148 Ayala-Grosso, 2006, Caspase-3 cleaved spectrin colocalizes with neurofilament-immunoreactive neurons in Alzheimer's disease, Neuroscience, 141, 863, 10.1016/j.neuroscience.2006.04.041 Bahr, 1991, Spectrin breakdown products increase with age in telencephalon of mouse brain, Neurosci. Lett., 131, 237, 10.1016/0304-3940(91)90622-Z Bennett, 2013, Spectrin- and ankyrin-based membrane domains and the evolution of vertebrates, Curr. Top. Membr., 72, 1, 10.1016/B978-0-12-417027-8.00001-5 Bernath, 2006, Elevation of cytoskeletal protein breakdown in aged Wistar rat brain, Neurobiol. Aging, 27, 624, 10.1016/j.neurobiolaging.2005.02.013 Bi, 1996, Regional distribution and time-course of calpain activation following kainate-induced seizure activity in adult rat brain, Brain Res., 726, 98, 10.1016/0006-8993(95)01360-1 Braak, 1991, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol., 82, 239, 10.1007/BF00308809 Brophy, 2009, ∀II-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury, J. Neurotrauma, 26, 471, 10.1089/neu.2008.0657 Cai, 2012, Age-related intraneuronal elevation of αII-spectrin breakdown product SBDP120 in rodent forebrain accelerates in 3×Tg-AD mice, PLoS One, 7, e37599, 10.1371/journal.pone.0037599 D'Amelio, 2011, Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease, Nat. Neurosci., 14, 69, 10.1038/nn.2709 Demuro, 2013, Cytotoxicity of intracellular aβ42 amyloid oligomers involves Ca2+ release from the endoplasmic reticulum by stimulated production of inositol trisphosphate, J. Neurosci., 33, 3824, 10.1523/JNEUROSCI.4367-12.2013 Fairless, 2014, Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration, Cell Tissue Res., 357, 455, 10.1007/s00441-013-1758-8 Higuchi, 2012, Mechanistic involvement of the calpain–calpastatin system in Alzheimer neuropathology, FASEB J., 26, 1204, 10.1096/fj.11-187740 Hwang, 2008, AlphaII-spectrin breakdown product increases in principal cells in the gerbil main olfactory bulb following transient ischemia, Neurosci. Lett., 435, 251, 10.1016/j.neulet.2008.02.050 Jellinger, 1998, The neuropathological diagnosis of Alzheimer disease, J. Neural Transm. Suppl., 53, 97, 10.1007/978-3-7091-6467-9_9 Lazzari, 2015, Aβ42 oligomers selectively disrupt neuronal calcium release, Neurobiol. Aging, 36, 877, 10.1016/j.neurobiolaging.2014.10.020 Lewis, 2007, Alpha-II spectrin breakdown products in aneurysmal subarachnoid hemorrhage: a novel biomarker of proteolytic injury, J. Neurosurg., 107, 792, 10.3171/JNS-07/10/0792 Liang, 2010, Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease, J. Biol. Chem., 285, 7737, 10.1074/jbc.M110.117960 Masliah, 1990, Increased immunoreactivity of brain spectrin in Alzheimer disease: a marker for synapse loss?, Brain Res., 531, 36, 10.1016/0006-8993(90)90755-Z Medeiros, 2012, Calpain inhibitor A-705253 mitigates Alzheimer's disease-like pathology and cognitive decline in aged 3×TgAD mice, Am. J. Pathol., 181, 616, 10.1016/j.ajpath.2012.04.020 Mondello, 2010, αII-Spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients, J. Neurotrauma, 27, 1203, 10.1089/neu.2010.1278 Montine, 2012, National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach, Acta Neuropathol., 123, 1, 10.1007/s00401-011-0910-3 Nath, 2000, Development and characterization of antibodies specific to caspase-3-produced alpha II-spectrin 120kDa breakdown product: marker for neuronal apoptosis, Neurochem. Int., 37, 351, 10.1016/S0197-0186(00)00040-1 Newcomb, 2000, Concurrent assessment of calpain and caspase-3 activity by means of western blots of protease-specific spectrin breakdown products, Methods Mol. Biol., 144, 219 Nicolas, 2014, The spectrin family of proteins: a unique coiled-coil fold for various molecular surface properties, J. Struct. Biol., 186, 392, 10.1016/j.jsb.2014.03.011 Pineda, 2004, Biomarkers of proteolytic damage following traumatic brain injury, Brain Pathol., 14, 202, 10.1111/j.1750-3639.2004.tb00054.x Ringger, 2001, A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels, J. Neurotrauma, 21, 1443, 10.1089/neu.2004.21.1443 Roselli, 2005, Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses, J. Neurosci., 25, 11061, 10.1523/JNEUROSCI.3034-05.2005 Saravanaraman, 2014, Why calcium channel blockers could be an elite choice in the treatment of Alzheimer's disease: a comprehensive review of evidences, Rev. Neurosci., 25, 231, 10.1515/revneuro-2013-0056 Schober, 2014, Alpha II spectrin breakdown products in immature Sprague Dawley rat hippocampus and cortex after traumatic brain injury, Brain Res., 1574, 105, 10.1016/j.brainres.2014.05.046 Snigdha, 2012, Caspase-3 activation as a bifurcation point between plasticity and cell death, Neurosci. Bull., 28, 14, 10.1007/s12264-012-1057-5 Tamada, 2005, Proteolysis of neuronal cytoskeletal proteins by calpain contributes to rat retinal cell death induced by hypoxia, Brain Res., 1050, 148, 10.1016/j.brainres.2005.05.048 Van Bergen, 2009, Recharacterization of the RGC-5 retinal ganglion cell line, Invest. Ophthalmol. Vis. Sci., 50, 4267, 10.1167/iovs.09-3484 Warren, 2007, Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA, Acta Neuropathol., 114, 277, 10.1007/s00401-007-0259-9 Wei, 2008, Role of calpain and caspase in beta-amyloid-induced cell death in rat primary septal cultured neurons, Neuropharmacology, 54, 721, 10.1016/j.neuropharm.2007.12.006 Weiss, 2009, Alpha II-spectrin breakdown products serve as novel markers of brain injury severity in a canine model of hypothermic circulatory arrest, Ann. Thorac. Surg., 88, 543, 10.1016/j.athoracsur.2009.04.016 Yan, 2012, Spectrin breakdown products (SBDPs) as potential biomarkers for neurodegenerative diseases, Curr. Transl. Geriatr. Exp. Gerontol. Rep., 1, 85, 10.1007/s13670-012-0009-2 Yan, 2001, Expression of active caspase-3 in mitotic and postmitotic cells of the rat forebrain, J. Comp. Neurol., 433, 4, 10.1002/cne.1121 Yan, 2015, Brain banking as a cornerstone of neuroscience in China, Lancet Neurol., 14, 136, 10.1016/S1474-4422(14)70259-5 Zhang, 2009, Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development, Eur. J. Neurosci., 30, 2271, 10.1111/j.1460-9568.2009.07017.x Zhang, 2009, Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways, Apoptosis, 14, 1289, 10.1007/s10495-009-0405-z